Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             412 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal vascular and neural retinal morphology in congenital lifetime isolated growth hormone deficiency Pereira-Gurgel, Virginia M.
 2016
 42-43 C p. 11-15
5 p.
 artikel
2 Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease Zhang, Sherry
 2018
 42-43 C p. 74-79
 artikel
3 A characteristic signature of insulin-like growth factor (IGF) axis expression during osteogenic differentiation of human dental pulp cells (hDPCs): Potential co-ordinated regulation of IGF action Al-Khafaji, Hasanain
 2018
 42-43 C p. 14-21
 artikel
4 A combined top-down and bottom-up LC-HRMS/MS method for the quantification of human growth hormone in plasma and serum Krombholz, Sophia
42-43 C p.
 artikel
5 A common deletion in the growth hormone receptor gene (d3-GHR) in the offspring is related to maternal placental GH levels during pregnancy Jensen, Rikke Beck
42-43 C p.
 artikel
6 A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury Yuen, Kevin C.J.
42-43 C p.
 artikel
7 Acromegaly in humans and cats: Pathophysiological, clinical and management resemblances and differences Lopes-Pinto, Mariana
42-43 C p.
 artikel
8 Acromegaly-related cutis verticis gyrata Roque, João
42-43 C p.
 artikel
9 Active recovery shows favorable IGF-I and IGF binding protein responses following heavy resistance exercise compared to passive recovery Taipale, R.S.
42-43 C p. 45-52
 artikel
10 A descriptive study on selected growth parameters and growth hormone receptor gene in healthy young adults from the American Midwest Hartin, Samantha N.
 2018
 42-43 C p. 48-53
 artikel
11 Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS) Charmandari, E.
42-43 C p.
 artikel
12 Administration of insulin like growth factor I (IGFI) lowers serum lipoprotein(a)-impact on atherosclerotic cardiovascular disease Laron, Zvi
42-43 C p.
 artikel
13 Adult growth hormone deficiency in CEE region: Heterogeneity of the patient pathway Shimon, Ilan
 2019
 42-43 C p. 44-49
 artikel
14 Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services Yuen, Kevin C.J.
42-43 C p.
 artikel
15 Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency Martín-Rivada, Álvaro
42-43 C p.
 artikel
16 Adult patients with Laron syndrome tend to develop the metabolic syndrome Laron, Zvi
42-43 C p.
 artikel
17 A first-in-man phase 1 trial for long-acting TransCon Growth Hormone Gilfoyle, David
 2018
 42-43 C p. 34-39
 artikel
18 Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study Durmuş, Elif Tutku
42-43 C p.
 artikel
19 Agreement between circulating IGF-I, IGFBP-1 and IGFBP-3 levels measured by current assays versus unavailable assays previously used in epidemiological studies Aneke-Nash, Chino S.
 2016
 42-43 C p. 11-16
6 p.
 artikel
20 A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective Rosenbloom, Arlan L.
 2016
 42-43 C p. 46-50
5 p.
 artikel
21 Aims & Scope/Editorial Board 2017
 42-43 C p. i-
1 p.
 artikel
22 Aims & Scope/Editorial Board 2017
 42-43 C p. i-
1 p.
 artikel
23 Aims & Scope/Editorial Board 2018
 42-43 C p. i
 artikel
24 Aims & Scope/Editorial Board 2018
 42-43 C p. i
 artikel
25 Aims & Scope/Editorial Board 2018
 42-43 C p. i
 artikel
26 Aims & Scope/Editorial Board 2017
 42-43 C p. i-
1 p.
 artikel
27 Aims & Scope/Editorial Board 2017
 42-43 C p. i-
1 p.
 artikel
28 Aims & Scope/Editorial Board 2018
 42-43 C p. i
 artikel
29 ALS deficiency caused by an exon 2 deletion and a novel missense variant in the gene encoding ALS Dominguez-Menéndez, Gonzalo
42-43 C p. 5-8
 artikel
30 Analyses of IGFBP2 DNA methylation and mRNA expression in visceral and subcutaneous adipose tissues of obese subjects Zhang, Xiuli
 2019
 42-43 C p. 31-36
 artikel
31 Analysis of new growth promoting black market products Krug, Oliver
 2018
 42-43 C p. 1-6
 artikel
32 Analysis of the IGF-system in milk from farm animals – Occurrence, regulation, and biomarker potential Meyer, Zianka
 2017
 42-43 C p. 1-7
7 p.
 artikel
33 Analyzing structural differences between insulin receptor (IR) and IGF1R for designing small molecule allosteric inhibitors of IGF1R as novel anti-cancer agents Bano, Nasima
42-43 C p.
 artikel
34 A novel GLI2 mutation responsible for congenital hypopituitarism and polymalformation syndrome Martín-Rivada, Álvaro
 2019
 42-43 C p. 17-19
 artikel
35 A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI) Ramírez, Laura
42-43 C p. 61-70
 artikel
36 A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I) Bright, George M.
42-43 C p.
 artikel
37 A review of renal GH/IGF1 family gene expression in chronic kidney diseases Brittain, Alison L.
42-43 C p. 1-4
 artikel
38 A single-center observational study assessing the predictive factors associated with the prognosis of acromegaly Diri, Halit
42-43 C p.
 artikel
39 Assessing insulin sensitivity and resistance in syndromes of severe short stature Guevara-Aguirre, Jaime
42-43 C p.
 artikel
40 Assessment of anterior pituitary reserve capacity based on growth hormone response to growth hormone-releasing peptide-2 test in the elderly Teramoto, Shinichiro
42-43 C p.
 artikel
41 Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study Ishii, Hitoshi
 2017
 42-43 C p. 36-43
8 p.
 artikel
42 Association between gestational diabetes mellitus and bioavailability of insulin-like growth factors and role of their binding proteins Anderlová, Kateřina
42-43 C p.
 artikel
43 Association between insulin-like growth factor 1 and pancreatic volume in type 1 and type 2 diabetes: cross-sectional study of a Japanese population Fukui, Tomoyasu
42-43 C p.
 artikel
44 Association of circulating leptin, growth hormone, and ghrelin with fibromyalgia: A meta-analysis Lee, Young Ho
42-43 C p.
 artikel
45 Association of rs35767 polymorphism in the IGF1 gene with athletic performance in power and endurance sports: A meta-analysis Mendes, João
42-43 C p.
 artikel
46 Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancer Barker, Rachel
42-43 C p.
 artikel
47 A summary of the influence of exogenous estrogen administration across the lifespan on the GH/IGF-1 axis and implications for bone health Southmayd, Emily A.
 2017
 42-43 C p. 2-13
 artikel
48 Atypical defects resulting in growth hormone insensitivity Wit, Jan M.
 2016
 42-43 C p. 57-61
5 p.
 artikel
49 A useful model to compare human and mouse growth hormone gene chromosomal structure, expression and regulation, and immune tolerance of human growth hormone analogues Cattini, Peter A.
 2018
 42-43 C p. 58-65
 artikel
50 Bioactive growth hormone in humans: Controversies, complexities and concepts Hymer, Wesley C.
42-43 C p. 9-22
 artikel
51 Bioactive growth hormone in older men and women: It's relationship to immune markers and healthspan Kraemer, William J.
 2017
 42-43 C p. 45-54
10 p.
 artikel
52 Bioavailable IGF-1 is beneficially associated with biomarkers of endothelial function in young healthy adults: The African-PREDICT study Barnard, Sunelle A.
 2018
 42-43 C p. 28-33
 artikel
53 Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly Peixe, Carolina
42-43 C p.
 artikel
54 Biomarkers of GH action in children and adults Schilbach, Katharina
 2018
 42-43 C p. 1-8
 artikel
55 Biomarkers of growth and carbohydrate metabolism in neonatal rats supplemented with fish oil and/or antioxidants during intermittent hypoxia Galetaki, Despoina Myrsini
42-43 C p.
 artikel
56 Broad variability in pharmacokinetics of GH following rhGH injections in children Lundberg, Elena
 2018
 42-43 C p. 61-68
 artikel
57 Cardiac functions in children with growth hormone deficiency: Effects of one year of GH replacement therapy Alkan, Fatos
42-43 C p.
 artikel
58 Cell-specific expression of insulin/insulin-like growth factor-I receptor hybrids in the mouse brain Martinez-Rachadell, L.
 2019
 42-43 C p. 25-30
 artikel
59 Challenges and future for the delivery of growth hormone therapy Caicedo, Andrés
 2018
 42-43 C p. 39-43
 artikel
60 Changes in anterior segment parameters and presence of dry eye disease in patients with acromegaly: A Sirius topography study combined with meibography Kilic, Deniz
42-43 C p.
 artikel
61 Changes in plasma amino acids metabolites, caused by long-term IGF-I deficiency, are reversed by IGF-I treatment – A pilot study Barazani, Chen
42-43 C p.
 artikel
62 Characterization of an intestine-specific GH receptor knockout (IntGHRKO) mouse Young, Jonathan A.
 2019
 42-43 C p. 5-15
 artikel
63 Characterization of a novel alternatively-spliced 5′ exon in the human insulin-like growth factor I (IGF-I) gene, expressed in liver and some cancers Wallis, Michael
 2019
 42-43 C p. 36-43
 artikel
64 Characterization of growth hormone disulfide-linked molecular isoforms during post-exercise release vs nocturnal pulsatile release reveals similar milieu composition Nindl, Bradley C.
 2018
 42-43 C p. 102-107
 artikel
65 Characterization of igf1 and igf2 genes during maraena whitefish (Coregonus maraena) ontogeny and the effect of temperature on embryogenesis and igf expression Nipkow, Mareen
 2018
 42-43 C p. 32-43
 artikel
66 Characterization of mouse pericardial fat: regulation by PAPP-A Bale, Laurie K.
 2018
 42-43 C p. 1-7
 artikel
67 Childhood growth hormone deficiency, a diagnosis in evolution: The intersection of growth hormone history and ethics Henry, Rohan K.
42-43 C p.
 artikel
68 Clinical and epidemiological characteristics, morbidity and treatment based on the registry of acromegalic patients in Colombia: RAPACO Castellanos-Bueno, Rafael
42-43 C p.
 artikel
69 Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment Vuralli, Dogus
 2017
 42-43 C p. 31-37
7 p.
 artikel
70 Combined simultaneous arginine clonidine stimulation test: Timing of peak growth hormone (GH) concentration and correlation with clinical indices of GH status Bhat, Nandini
 2018
 42-43 C p. 28-31
 artikel
71 Comparative pharmacokinetic and pharmacodynamic evaluation between a new biosimilar and reference recombinant human growth hormone Toffoletto, Odaly
 2016
 42-43 C p. 31-36
6 p.
 artikel
72 Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency Ciresi, Alessandro
 2018
 42-43 C p. 40-44
 artikel
73 Comparison of growth response and adverse reaction according to growth hormone dosing strategy for children with short stature: LG Growth Study Song, Kyungchul
42-43 C p.
 artikel
74 Comparison of hyperoxia or normoxia resolution of intermittent hypoxia and intermittent hyperoxia episodes on liver histopathology, IGF-1, IGFBP-3, and GHBP in neonatal rats Cai, Charles L.
42-43 C p.
 artikel
75 Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children Hou, Ling
42-43 C p.
 artikel
76 Comparison of two prediction models in a clinical setting to predict growth in prepubertal children on recombinant growth hormone Ly, Helena-Jamin
42-43 C p.
 artikel
77 Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study Hansen-Pupp, Ingrid
 2017
 42-43 C p. 44-51
8 p.
 artikel
78 Corrigendum to ‘A novel gross indel in the growth hormone releasing hormone receptor gene of Indian IGHD patients.’ [Growth Hormone & IGF Research 24 (2014) 227–232] Kale, Shantanu
42-43 C p. 75-76
 artikel
79 Corrigendum to “Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study” [Growth Hormon. IGF Res. 36 (2017) 36–43] Ishii, Hitoshi
 2018
 42-43 C p. 74-75
 artikel
80 Corrigendum to “Effects of a home-based exercise program on the insulin-like growth factor axis in patients operated for colorectal cancer in Sweden: Results from the randomised controlled trial PHYSSURG-C” Growth Hormone & IGF Research (2020) 27–33 Onerup, Aron
42-43 C p.
 artikel
81 Corrigendum to “Insulin-like growth Factors I and II receptors in the breast cancer disparity” among African-American women [Growth Hormone & IGF Research 20 (2010) 245–254] Singh, S. Kalla
42-43 C p.
 artikel
82 Corrigendum to “Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients”, [Growth Hormone & IGF Research, Volume 55, December 2020, 101335] Uygur, Meliha Melin
42-43 C p.
 artikel
83 Corrigendum to “Pharmacodynamics, pharmacokinetics, and toxicology of Fc-growth hormone fusion protein in macaques” Liu, Han
42-43 C p.
 artikel
84 Corrigendum to “Professor Kerstin Hall (1929–2017): Pioneer in the field of Growth Hormone and IGF Research” [Growth Horm. IGF Res. 34 (2017) 28–30. doi: 10.1016/j.ghir.2017.05.001. Epub 2017 May 3] Lewitt, M.S.
 2017
 42-43 C p. 57-
1 p.
 artikel
85 Corrigendum to Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone? Growth Hormone & IGF Research 45 (2019) 20–24 Sze, Lisa
42-43 C p. 77
 artikel
86 Cortistatin: A new link between the growth hormone/prolactin axis, stress, and metabolism Ibáñez-Costa, Alejandro
 2017
 42-43 C p. 23-27
5 p.
 artikel
87 Could calgranulins and advanced glycated end products potentiate acromegaly pathophysiology? Kruse, Colin P.S.
 2019
 42-43 C p. 1-4
 artikel
88 Course and outcomes of pregnancy in women treated for acromegaly: Discerning a contemporary cohort Das, Liza
42-43 C p.
 artikel
89 Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology Jensen, Elizabeth A.
42-43 C p.
 artikel
90 Current ideas on the biology of IGFBP-6: More than an IGF-II inhibitor? Bach, Leon A.
 2016
 42-43 C p. 81-86
6 p.
 artikel
91 David B. Dunger: in memoriam 1948–2021 Yuen, KevinC.J.
42-43 C p.
 artikel
92 Decreased insulin-like growth factor-1 expression in response to mechanical loading is associated with skeletal muscle anabolic resistance in cancer cachexia Miyazaki, Mitsunori
42-43 C p.
 artikel
93 Dental arches in inherited severe isolated growth hormone deficiency Girão, Rafaela S.
42-43 C p.
 artikel
94 Depot-specific and GH-dependent regulation of IGF binding protein-4, pregnancy-associated plasma protein-A, and stanniocalcin-2 in murine adipose tissue Hjortebjerg, Rikke
 2018
 42-43 C p. 54-61
 artikel
95 Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives Guevara-Aguirre, Jaime
 2016
 42-43 C p. 76-78
3 p.
 artikel
96 Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS Thomas, Andreas
 2017
 42-43 C p. 33-39
7 p.
 artikel
97 Development of a novel assay for IGFBP-2 complexed with IGF-I and-II in human serum Agerholm, Jonas
42-43 C p. 38-45
 artikel
98 Differential basal and exercise-induced IGF-I system responses to resistance vs. calisthenic-based military readiness training programs Nindl, Bradley C.
 2017
 42-43 C p. 33-40
 artikel
99 Differential effects of androgens and estrogens over cellular GH sensitivity in HEPG2 cells Ocaranza, Paula
42-43 C p.
 artikel
100 Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence Somri, Lina
 2018
 42-43 C p. 6-12
 artikel
101 Digital technologies to improve the precision of paediatric growth disorder diagnosis and management Dunkel, Leo
42-43 C p.
 artikel
102 Discrepancies in insulin-like growth factor signaling? No, not really Conover, Cheryl A.
 2016
 42-43 C p. 42-44
3 p.
 artikel
103 Disrupted harmony of the skull skeleton: Middle ear resonance in acromegaly Kaya Çelik, Elif
42-43 C p.
 artikel
104 Disruption of the GH receptor gene in adult mice and in insulin sensitive tissues Duran-Ortiz, Silvana
 2018
 42-43 C p. 3-7
 artikel
105 Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies Liu, Zhongbo
 2016
 42-43 C p. 7-17
11 p.
 artikel
106 Do neurosteroids have impact on depression and cognitive functions in cases with acromegaly? Hatipoglu, Esra
42-43 C p.
 artikel
107 Duration-specific association between plasma IGFBP7 levels and diabetic complications in patients with type 2 diabetes mellitus Zhu, Xiaoyan
42-43 C p.
 artikel
108 Early cessation and non-response are important and possibly related problems in growth hormone therapy: An OZGROW analysis Hughes, Ian P.
 2016
 42-43 C p. 63-70
8 p.
 artikel
109 Economic and clinical burden of comorbidities among patients with acromegaly Whittington, Melanie D.
42-43 C p.
 artikel
110 Editorial 2017
 42-43 C p. 1
 artikel
111 Editorial Board 2016
 42-43 C p. i-
1 p.
 artikel
112 Editorial Board 2017
 42-43 C p. i-
1 p.
 artikel
113 Editorial Board 2016
 42-43 C p. i-
1 p.
 artikel
114 Editorial Board
42-43 C p.
 artikel
115 Editorial Board
42-43 C p.
 artikel
116 Editorial Board
42-43 C p.
 artikel
117 Editorial Board
42-43 C p.
 artikel
118 Editorial Board
42-43 C p.
 artikel
119 Editorial Board 2016
 42-43 C p. i-
1 p.
 artikel
120 Editorial Board 2017
 42-43 C p. i
 artikel
121 Editorial Board 2016
 42-43 C p. i-
1 p.
 artikel
122 Editorial Board 2016
 42-43 C p. i-
1 p.
 artikel
123 Editorial Board 2018
 42-43 C p. ii
 artikel
124 Editorial Board 2019
 42-43 C p. ii
 artikel
125 Editorial Board 2019
 42-43 C p. ii
 artikel
126 Editorial Board
42-43 C p. ii
 artikel
127 Editorial Board 2019
 42-43 C p. ii
 artikel
128 Editorial Board
42-43 C p.
 artikel
129 Editorial Board
42-43 C p.
 artikel
130 Editorial Board
42-43 C p.
 artikel
131 Editorial Board
42-43 C p.
 artikel
132 Editorial Board
42-43 C p.
 artikel
133 Editorial Board
42-43 C p.
 artikel
134 Editorial Board
42-43 C p.
 artikel
135 Editorial Board
42-43 C p. ii
 artikel
136 Editorial Board
42-43 C p. ii
 artikel
137 Editorial Board
42-43 C p.
 artikel
138 Editorial Board
42-43 C p.
 artikel
139 Editorial Board
42-43 C p.
 artikel
140 Editorial Board
42-43 C p.
 artikel
141 Editorial Board
42-43 C p.
 artikel
142 Editorial Board
42-43 C p.
 artikel
143 Editorial Board
42-43 C p.
 artikel
144 Editorial Board
42-43 C p.
 artikel
145 Editorial Board
42-43 C p.
 artikel
146 Editorial Board
42-43 C p.
 artikel
147 Editorial Board
42-43 C p.
 artikel
148 Editorial Board
42-43 C p.
 artikel
149 Editor Note Yuen, Kevin C.J.
42-43 C p.
 artikel
150 Effect of a copper intrauterine device on HLA-G and IGF-II levels during pregnancy Cao, Lili
42-43 C p.
 artikel
151 Effect of amino acids on IGF1 gene expression in human myotubes and skeletal muscle Lednev, Egor M.
42-43 C p.
 artikel
152 Effect of growth hormone treatment on circulating levels of NT-proBNP in patients with ischemic heart failure Karason, Kristjan
42-43 C p.
 artikel
153 Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly Fazeli, Pouneh K.
 2016
 42-43 C p. 17-23
7 p.
 artikel
154 Effect of long-acting growth hormone treatment on endogenous growth hormone secretion in prepubertal patients with idiopathic short stature: A preliminary study Choi, Han Saem
42-43 C p.
 artikel
155 Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study Sulu, Cem
42-43 C p.
 artikel
156 Effects of a home-based exercise program on the insulin-like growth factor axis in patients operated for colorectal cancer in Sweden: Results from the randomised controlled trial PHYSSURG-C Onerup, Aron
42-43 C p. 27-33
 artikel
157 Effects of gender, body weight, and blood glucose dynamics on the growth hormone response to the glucagon stimulation test in patients with pituitary disease Wilson, Jessica R.
 2016
 42-43 C p. 24-31
8 p.
 artikel
158 Effects of growth hormone on uncoupling protein 1 in white adipose tissues in obese mice Hayashi, Misa
 2017
 42-43 C p. 31-39
9 p.
 artikel
159 Effects of growth hormone-releasing hormone gene targeted ablation on ghrelin-induced feeding Recinella, Lucia
 2017
 42-43 C p. 40-46
7 p.
 artikel
160 Effects of high-dose all-trans retinoic acid on longitudinal bone growth of young rats Shen, Qin
42-43 C p.
 artikel
161 Effects of 18 months of GH replacement on cardiovascular risk factors and quality of life in GH deficient adults; a randomized controlled trial using a fixed very low and a standard dose of GH Götherström, Galina
42-43 C p.
 artikel
162 Effects of raloxifene administration on serum levels of insulin-like growth factor-1 and insulin-like growth factor-binding protein 3 levels: A systematic review and meta-analysis of randomized controlled trials Sun, Yan
42-43 C p.
 artikel
163 Effects of sustained release growth hormone treatment during the rehabilitation of adult severe burn survivors Kim, June-Bum
 2016
 42-43 C p. 1-6
6 p.
 artikel
164 Efficacy and predictors of short-term first-generation somatostatin analog presurgical treatment in acromegaly: A hospital-based study of 237 cases Shen, Ming
42-43 C p.
 artikel
165 Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial Czepielewski, M.A.
42-43 C p. 29-35
 artikel
166 Efficacy and safety of growth hormone therapy in children with Noonan syndrome Sodero, Giorgio
42-43 C p.
 artikel
167 Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature Ying, Yan-Qin
 2018
 42-43 C p. 80-85
 artikel
168 Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants Klevebro, Susanna
42-43 C p. 1-8
 artikel
169 Emotional state, cognitive functioning and quality of life of adult women with Turner syndrome in Lithuania Lašaitė, L.
 2019
 42-43 C p. 37-42
 artikel
170 Endoplasmic reticulum stress induces growth retardation by inhibiting growth hormone IGF-I axis Xia, Wanjun
42-43 C p.
 artikel
171 Endothelial dysfunction in patients with acromegaly and It's association with Endocan Kul, Seref
42-43 C p.
 artikel
172 Endurance training-induced changes in the GH-IGF-I axis influence maximal muscle strength in previously untrained men Grandys, Marcin
 2017
 42-43 C p. 41-48
 artikel
173 Epilogue: The future of Laron syndrome — The need for changes Laron, Zvi
 2016
 42-43 C p. 79-80
2 p.
 artikel
174 Estimation of glucose utilization in a type 2 diabetes mellitus patient on insulin analogs with tumor hypoglycemia induced by IGF-II Chode, Suresh
 2016
 42-43 C p. 8-10
3 p.
 artikel
175 Estradiol and corticosterone stimulate the proliferation of a GH cell line, MtT/S Nogami, Haruo
 2016
 42-43 C p. 33-38
6 p.
 artikel
176 Evaluation of growth hormone deficiency in women with unexplained infertility Ortac, Mehmet Serif
42-43 C p.
 artikel
177 Evaluation of the GHRH–arginine retest for young adolescents with childhood-onset GH deficiency Dreismann, Laura
 2016
 42-43 C p. 28-32
5 p.
 artikel
178 Exercise combined with lysine-inositol vitamin B12 promotes height growth in children with idiopathic short stature Sun, Fengping
42-43 C p.
 artikel
179 Exercise training with blood flow restriction has little effect on muscular strength and does not change IGF-1 in fit military warfighters Jensen, Andrew E.
 2016
 42-43 C p. 33-40
8 p.
 artikel
180 Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Osganian, Stephanie A.
42-43 C p.
 artikel
181 Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects Matsumoto, Ryusaku
 2018
 42-43 C p. 55-60
 artikel
182 Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation Braun, Laurie R.
 2017
 42-43 C p. 1-6
6 p.
 artikel
183 Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice Brooks, Nicole E.
 2016
 42-43 C p. 22-30
9 p.
 artikel
184 Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients—From discovery to treatment Laron, Zvi
 2016
 42-43 C p. 53-56
4 p.
 artikel
185 First-in-man study with a novel PEGylated recombinant human insulin-like growth factor-I Kletzl, H.
 2017
 42-43 C p. 9-16
8 p.
 artikel
186 First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy Puglisi, Soraya
 2019
 42-43 C p. 17-19
 artikel
187 FNDC5 relates to skeletal muscle IGF-I and mitochondrial function and gene expression in obese men with reduced growth hormone Srinivasa, Suman
 2016
 42-43 C p. 36-41
6 p.
 artikel
188 Foreword from the editors Guevara-Aguirre, Jaime
 2016
 42-43 C p. 1-
1 p.
 artikel
189 Foreword from the guest editors Guevara-Aguirre, Jaime
 2018
 42-43 C p. 2
 artikel
190 Foreword from the guest editors Guevara-Aguirre, Jaime
42-43 C p.
 artikel
191 From dwarves to giants: South American's contribution to the history of growth hormone and related disorders Boguszewski, Cesar Luiz
42-43 C p. 48-56
 artikel
192 Gender has to be taken into account in diagnosing adult growth hormone deficiency by the GHRH plus arginine test Markkanen, Helene M.
 2017
 42-43 C p. 52-56
5 p.
 artikel
193 Genetic disorders of GH action pathway Domené, Horacio M.
 2018
 42-43 C p. 19-23
 artikel
194 Genetic short stature Grunauer, Michelle
 2018
 42-43 C p. 29-33
 artikel
195 Genetics of gigantism and acromegaly Hannah-Shmouni, Fady
 2016
 42-43 C p. 37-41
5 p.
 artikel
196 GH administration decreases subcutaneous abdominal adipocyte size in men with abdominal obesity Bredella, Miriam A.
 2017
 42-43 C p. 17-20
4 p.
 artikel
197 GH and GHR signaling in human disease Guevara-Aguirre, Jaime
 2018
 42-43 C p. 34-38
 artikel
198 GH directly stimulates UCP3 expression Hayashi, Misa
 2018
 42-43 C p. 44-54
 artikel
199 GH replacement titrated to serum IGF-1 does not reduce concentrations of myostatin in blood or skeletal muscle Paul, Ryan G.
 2019
 42-43 C p. 11-16
 artikel
200 GH responses to whole body vibration alone or in combination with maximal voluntary contractions in obese male adolescents Rigamonti, A.E.
 2018
 42-43 C p. 22-27
 artikel
201 GHRH expression plasmid improves osteoporosis and skin damage in aged mice Ye, Rui
42-43 C p.
 artikel
202 GHRH plus arginine and arginine administration evokes the same ratio of GH isoforms levels in young patients with Prader-Willi syndrome Rigamonti, Antonello E.
 2018
 42-43 C p. 13-18
 artikel
203 Gigantism: X-linked acrogigantism and GPR101 mutations Iacovazzo, Donato
 2016
 42-43 C p. 64-69
6 p.
 artikel
204 Growth and growth hormone: An overview Teran, Enrique
 2016
 42-43 C p. 3-5
3 p.
 artikel
205 Growth, development, puberty and adult height of patients with congenital multiple pituitary hormone deficiencies Haim-Pinhas, Hadar
 2016
 42-43 C p. 46-52
7 p.
 artikel
206 Growth factors, aging and age-related diseases Balasubramanian, Priya
 2016
 42-43 C p. 66-68
3 p.
 artikel
207 Growth hormone activated STAT5 is required for induction of beige fat in vivo Nelson, Caroline N.
 2018
 42-43 C p. 40-51
 artikel
208 Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression Villanueva-Ortega, Eréndira
42-43 C p.
 artikel
209 Growth hormone and hematopoiesis: A retrospective analysis on a large cohort of children with growth hormone deficiency Ciresi, Alessandro
 2018
 42-43 C p. 8-13
 artikel
210 Growth hormone and insulin-like growth factor-I axis in type 1 diabetes Nambam, Bimota
 2018
 42-43 C p. 49-52
 artikel
211 Growth hormone and Insulin-like growth factor-I (IGF-I) modulate the expression of L-type amino acid transporters in the muscles of spontaneous dwarf rats and L6 and C2C12 myocytes Sawa, Ran
 2018
 42-43 C p. 66-73
 artikel
212 Growth hormone and ocular dysfunction: Endocrine, paracrine or autocrine etiologies? Harvey, Steve
 2016
 42-43 C p. 28-32
5 p.
 artikel
213 Growth hormone deficiency, acromegaly and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis Yuen, Kevin C.J.
42-43 C p.
 artikel
214 Growth hormone directly stimulates GATA2 expression Mitsutani, Mana
42-43 C p.
 artikel
215 Growth hormone facilitates 5′-azacytidine-induced myogenic but inhibits 5′-azacytidine-induced adipogenic commitment in C3H10T1/2 mesenchymal stem cells Jia, Dan
 2018
 42-43 C p. 9-16
 artikel
216 Growth hormone increases dendritic spine density in primary hippocampal cell cultures Nylander, Erik
42-43 C p. 42-47
 artikel
217 Growth hormone inhibits adipogenic differentiation and induces browning in bovine subcutaneous adipocytes Li, Tingting
42-43 C p.
 artikel
218 Growth hormone modulates Trypanosoma cruzi infection in vitro Mora-Criollo, Patricia
42-43 C p.
 artikel
219 Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity Guevara-Aguirre, Jaime
42-43 C p. 58-64
 artikel
220 Growth hormone receptor (GHR) gene polymorphism and scoliosis in Prader-Willi syndrome Butler, Merlin G.
 2018
 42-43 C p. 29-33
 artikel
221 Growth hormone regulates the expression of UCP2 in myocytes Futawaka, Kumi
 2016
 42-43 C p. 57-62
6 p.
 artikel
222 Growth hormone-releasing hormone antagonists counteract hydrogen peroxide – induced paracellular hyperpermeability in endothelial cells Barabutis, Nektarios
42-43 C p.
 artikel
223 Growth hormone replacement in adults: Real-world data from two large studies in US and Europe Weber, Matthias M.
42-43 C p. 71-82
 artikel
224 Growth hormone replacement may influence the biological action of thyroid hormone on liver and bone tissue Glynn, Nigel
42-43 C p.
 artikel
225 Growth hormone responses during arginine and clonidine stimulation test: Correlations with patients' auxological and metabolic parameters in a single centre study Sodero, Giorgio
42-43 C p.
 artikel
226 Growth hormone secreting pituitary carcinomas: Case report and review of literature Vekaria, Shivani
42-43 C p.
 artikel
227 Growth hormone signaling in fibroblasts from newborn boys and prepubertal boys Ocaranza, Paula
 2016
 42-43 C p. 18-27
10 p.
 artikel
228 Growth hormone signaling pathways Carter-Su, Christin
 2016
 42-43 C p. 11-15
5 p.
 artikel
229 Growth hormone therapy for children with Duchenne muscular dystrophy and glucocorticoid induced short stature Lavi, Eran
42-43 C p.
 artikel
230 Growth hormone therapy in children; research and practice – A review Collett-Solberg, Paulo Ferrez
 2019
 42-43 C p. 20-32
 artikel
231 Growth hormone treatment in aged patients with comorbidities: A systematic review Tausendfreund, Olivia
42-43 C p.
 artikel
232 Growth of teeth and bones in adult subjects with congenital untreated isolated growth hormone deficiency Oliveira-Neto, Luiz A.
42-43 C p.
 artikel
233 High-dose atorvastatin is associated with lower IGF-1 levels in patients with type 1 diabetes Bergen, Karin
 2016
 42-43 C p. 78-82
5 p.
 artikel
234 High-intensity interval exercise test stimulates growth hormone secretion in children Dror, Nitzan
42-43 C p.
 artikel
235 High prevalence of the IGF2 rs680 GG polymorphism among top-level sprinters and jumpers Ben-Zaken, Sigal
 2017
 42-43 C p. 26-30
5 p.
 artikel
236 Hormonal, metabolic, and angiogenic responses to all-out sprint interval exercise under systemic hyperoxia Kon, Michihiro
42-43 C p.
 artikel
237 Hormonal stress responses of growth hormone and insulin-like growth factor-I in highly resistance trained women and men Hatfield, Disa L.
42-43 C p.
 artikel
238 Humanin: Functional Interfaces with IGF-I Xiao, J.
 2016
 42-43 C p. 21-27
7 p.
 artikel
239 Human placental growth hormone in ectopic pregnancy: Detection in maternal blood, immunohistochemistry and potential clinical implication Hübener, Christoph
 2017
 42-43 C p. 13-18
6 p.
 artikel
240 Hypothalamic abnormalities: Growth failure due to defects of the GHRH receptor Aguiar-Oliveira, Manuel H.
 2018
 42-43 C p. 14-18
 artikel
241 Identification and characterization of circular RNAs in chicken hepatocytes Zhang, Li
 2019
 42-43 C p. 16-23
 artikel
242 Identification of novel GHRHR and GH1 mutations in patients with isolated growth hormone deficiency Birla, Shweta
 2016
 42-43 C p. 50-56
7 p.
 artikel
243 Identification of the IGF-1 processing product human Ec/rodent Eb peptide in various tissues: Evidence for its differential regulation after exercise-induced muscle damage in humans Vassilakos, George
 2017
 42-43 C p. 22-28
 artikel
244 IGF-1 and cardiovascular disease Higashi, Yusuke
 2019
 42-43 C p. 6-16
 artikel
245 IGFBP-4 and PAPP-A in normal physiology and disease Hjortebjerg, Rikke
 2018
 42-43 C p. 7-22
 artikel
246 IGF-I in the clinics: Use in retinopathy of prematurity Hellström, Ann
 2016
 42-43 C p. 75-80
6 p.
 artikel
247 IGF-1 knockdown inhibits phosphorylation of Akt and ERK in chicken embryonic myotubes Saneyasu, Takaoki
42-43 C p.
 artikel
248 IGF research 2016–2018 Takahashi, Shin-Ichiro
42-43 C p. 65-69
 artikel
249 IGF-1R mRNA expression is increased in obese children Ricco, Rafaela Cristina
 2018
 42-43 C p. 1-5
 artikel
250 Illness-related burden, personal resources and need for support in patients with acromegaly: Results of a focus group analysis Siegel, Sonja
42-43 C p.
 artikel
251 Impact of disease activity on cognitive and psychological outcomes in acromegaly: A prospective study Uysal, Serhat
42-43 C p.
 artikel
252 Impact of GH administration on athletic performance in healthy young adults: A systematic review and meta-analysis of placebo-controlled trials Hermansen, Kasper
 2017
 42-43 C p. 38-44
7 p.
 artikel
253 Impact of short stature on quality of life: A systematic literature review Backeljauw, Philippe
42-43 C p.
 artikel
254 Impaired repletion of intramyocellular lipids in patients with growth hormone deficiency after a bout of aerobic exercise Loher, Hannah
 2018
 42-43 C p. 32-39
 artikel
255 Increased fibrosis: A novel means by which GH influences white adipose tissue function Householder, Lara A.
 2018
 42-43 C p. 45-53
 artikel
256 Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity Hellgren, Gunnel
 2018
 42-43 C p. 19-24
 artikel
257 Increase of serum lipoprotein (a), an adverse effect of growth hormone treatment Laron, Zvi
42-43 C p.
 artikel
258 In missed abortion the decrease of IGF-1 down-regulates PI3K/AKT signaling pathway reducing the secretion of progesterone and β-hCG Liang, Weitao
42-43 C p.
 artikel
259 Insights from an advisory board: Facilitating transition of care into adulthood in brain cancer survivors with acquired pediatric growth hormone deficiency Alter, Craig
42-43 C p.
 artikel
260 Insulin-like growth factor-1 directly mediates expression of mitochondrial uncoupling protein 3 via forkhead box O4 Watamoto, Yukiko
 2019
 42-43 C p. 24-35
 artikel
261 Insulin-like growth factor (IGF) performance in ovarian function and applications in reproductive biotechnologies Piau, Tathyana Benetis
42-43 C p.
 artikel
262 Insulin resistance depends on GH counter-regulation in two syndromes of short stature Guevara-Aguirre, Jaime
 2018
 42-43 C p. 44-48
 artikel
263 Integrated analysis of noncoding RNAs and mRNAs reveals their potential roles in the biological activities of the growth hormone receptor Chang, Lei
 2016
 42-43 C p. 11-20
10 p.
 artikel
264 Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver Cai, Charles
 2018
 42-43 C p. 54-63
 artikel
265 Investigation of IGF2, IGFBP2 and p63 proteins in rhabdomyosarcoma tumors Yu, Yongbo
 2017
 42-43 C p. 17-22
6 p.
 artikel
266 Is growth hormone deficiency associated with anxiety disorder and depressive symptoms in children and adolescents?: A case-control study Akaltun, İsmail
 2018
 42-43 C p. 23-27
 artikel
267 Lacrimal gland enlargement and tear film changes in acromegaly patients: A controlled study Mergen, Burak
42-43 C p.
 artikel
268 Lessons learned from studies with the growth hormone receptor Kopchick, John J.
 2016
 42-43 C p. 21-25
5 p.
 artikel
269 Letter to the Editor: History and clinical implications of PAPP-A2 in human growth: When reflecting on idiopathic short stature leads to a specific and new diagnosis Argente, Jesús
 2018
 42-43 C p. 17-19
 artikel
270 Linkage between growth retardation and pituitary cell morphology in a dystrophin-deficient pig model of Duchenne muscular dystrophy Hofmann, I.
42-43 C p. 6-16
 artikel
271 Liver and muscle-specific effects of phoenixin-20 on the insulin-like growth factor system mRNAs in zebrafish Rajeswari, Jithine Jayakumar
42-43 C p.
 artikel
272 Long-term adherence to growth hormone therapy in a large health maintenance organization cohort Farfel, Alon
 2019
 42-43 C p. 1-5
 artikel
273 Long-term endocrinological outcomes of gamma knife radiosurgery in acromegaly patients Uygur, Meliha Melin
42-43 C p.
 artikel
274 Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens Scheermeyer, Elly
 2017
 42-43 C p. 1-7
7 p.
 artikel
275 Mechanisms of putative IGF-I receptor resistance in active acromegaly Janssen, Joseph A.M.J.L.
42-43 C p.
 artikel
276 Medical treatment of acromegaly – When the tumor size matters: A narrative review Doknic, Mirjana
42-43 C p.
 artikel
277 Meta-analysis of MspI derived variants of growth hormone gene associated with milk yield in dairy cattle Bangar, Yogesh C.
42-43 C p.
 artikel
278 Metabolic and quality of life effects of growth hormone replacement in patients with TBI and AGHD: A pilot study Herodes, Megan
42-43 C p.
 artikel
279 Metabolic differences between short children with GH peak levels in the lower normal range and healthy children of normal height Tidblad, Anders
 2017
 42-43 C p. 22-27
6 p.
 artikel
280 Metabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatment Mastrangelo, Annalaura
 2018
 42-43 C p. 28-31
 artikel
281 Molecular and cellular effects of insulin-like growth factor-1 and LongR3-IGF-1 on in vitro maturation of bovine oocytes: comparative study Araujo, M.S.
42-43 C p.
 artikel
282 Multi-modal exercise training and protein-pacing enhances physical performance adaptations independent of growth hormone and BDNF but may be dependent on IGF-1 in exercise-trained men Ives, Stephen J.
 2017
 42-43 C p. 60-70
 artikel
283 Mutations in GH1 gene and isolated growth hormone deficiency (IGHD): A familial case of IGHD type I and systematic review Li, Qiuyue
42-43 C p.
 artikel
284 New genetic tools in the diagnosis of growth defects Dauber, Andrew
 2018
 42-43 C p. 24-28
 artikel
285 New medical therapies of acromegaly Maffezzoni, F.
 2016
 42-43 C p. 58-63
6 p.
 artikel
286 Nicotine inhibits expression of Prrx1 in pituitary stem/progenitor cells through epigenetic regulation, leading to a delayed supply of growth-hormone-producing cells Hibara, Ayaka
42-43 C p. 65-74
 artikel
287 Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone Thygesen, Peter
 2017
 42-43 C p. 8-16
9 p.
 artikel
288 Novel gross deletion at the GHRHR gene locus possibly mediated by Alu specific microhomology identified in a Sri Lankan patient with isolated growth hormone deficiency Sundralingam, Tharmini
 2018
 42-43 C p. 94-101
 artikel
289 Novel gross deletion at the LHX4 gene locus in a child with growth hormone deficiency Samarasinghe, Saumya Madushani
42-43 C p.
 artikel
290 Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred Marinho, Cindi G.
 2018
 42-43 C p. 71-74
 artikel
291 Ocular findings in adult subjects with an inactivating mutation in GH releasing hormone receptor gene Faro, Augusto C.N.
 2017
 42-43 C p. 8-12
5 p.
 artikel
292 PAPP-A activity is increased in cerebrospinal fluid from patients with diabetic polyneuropathy and correlates with peripheral nerve impairment Kallestrup, M.
42-43 C p. 53-59
 artikel
293 Pappa2 deletion has sex- and age-specific effects on bone in mice Christians, Julian K.
 2019
 42-43 C p. 6-10
 artikel
294 Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients Düğer, Hakan
42-43 C p.
 artikel
295 Partial correction of the dwarf phenotype by non-viral transfer of the growth hormone gene in mice: Treatment age is critical Higuti, Eliza
 2016
 42-43 C p. 1-7
7 p.
 artikel
296 Passing on the baton
42-43 C p. iii
 artikel
297 Pathogenic and likely pathogenic genetic alterations and polymorphisms in growth hormone gene (GH1) and growth hormone releasing hormone receptor gene (GHRHR) in a cohort of isolated growth hormone deficient (IGHD) children in Sri Lanka Sundralingam, Tharmini
 2017
 42-43 C p. 22-29
8 p.
 artikel
298 Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas Ozkaya, Hande Mefkure
42-43 C p.
 artikel
299 Pediatric growth hormone deficiency: Understanding the patient and caregiver perspectives Miller, Bradley S.
42-43 C p.
 artikel
300 Personality traits in acromegalic patients: Comparison with patients with non-functioning adenomas and healthy controls Kan, Elif Kilic
42-43 C p.
 artikel
301 Pharmacodynamics, pharmacokinetics, and toxicology of Fc-growth hormone fusion protein in macaques Liu, Han
42-43 C p.
 artikel
302 Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study Owada, Yasuko
42-43 C p.
 artikel
303 Phenotype analysis of male transgenic mice overexpressing mutant IGFBP-2 lacking the Cardin–Weintraub sequence motif: Reduced expression of synaptic markers and myelin basic protein in the brain and a lower degree of anxiety-like behaviour Schindler, N.
 2017
 42-43 C p. 1-8
8 p.
 artikel
304 Physical activity, dietary protein and insulin-like growth factor 1: Cross-sectional analysis utilising UK Biobank Gulick, C.N.
42-43 C p.
 artikel
305 Potential applications for rhIGF-I: Bone disease and IGFI Bahamonde, Marisol
42-43 C p.
 artikel
306 Preface Gangotena, Santiago
 2016
 42-43 C p. 2-
1 p.
 artikel
307 Preface Montúfar, Carlos
 2018
 42-43 C p. 1
 artikel
308 Preface Montúfar, Carlos
42-43 C p.
 artikel
309 Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular disease Conover, Cheryl A.
42-43 C p.
 artikel
310 Pregnancy-associated plasma proteins and Stanniocalcin-2 – Novel players controlling IGF-I physiology Frystyk, Jan
42-43 C p.
 artikel
311 Prevalence and predictors of abnormal glucose tolerance and its resolution in acromegaly: Single Centre retrospective study of 90 cases Khaire, Suhas S.
42-43 C p.
 artikel
312 Prevalence of refractoriness when testing growth hormone levels in children Borghammar, Camilla
42-43 C p.
 artikel
313 Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study Spricido, Isadora Yasbick
42-43 C p.
 artikel
314 p.R209H GH1 variant challenges short stature assessment Sanguineti, Nora
42-43 C p. 23-26
 artikel
315 Professor Kerstin Hall (1929–2017): Pioneer in the field of growth hormone and IGF research Lewitt, Moira S.
 2017
 42-43 C p. 28-30
3 p.
 artikel
316 Progression from isolated growth hormone deficiency to combined pituitary hormone deficiency Cerbone, Manuela
 2017
 42-43 C p. 19-25
7 p.
 artikel
317 Prolactin response to growth hormone stimulation tests Silbergeld, Avivah
42-43 C p.
 artikel
318 Prostate-specific antigen (PSA) levels in men with Prader-Willi syndrome Oskarsson, Anna
42-43 C p.
 artikel
319 Pulse wave velocity is decreased in acromegaly compared to non-acromegaly study participants with similar cardiovascular risk profile Filchenko, Irina
42-43 C p.
 artikel
320 Quantitative Western ligand blotting reveals common patterns and differential features of IGFBP-fingerprints in domestic ruminant breeds and species Wirthgen, Elisa
 2016
 42-43 C p. 42-49
8 p.
 artikel
321 Rapid height growth after liver transplantation in adulthood Szili, Balázs
 2016
 42-43 C p. 1-3
3 p.
 artikel
322 Recombinant human IGF-1 produced by transgenic plant cell suspension culture enhances new bone formation in calvarial defects Poudel, Sher Bahadur
 2017
 42-43 C p. 1-10
10 p.
 artikel
323 Recombinant IGF-I: Past, present and future Bright, George M.
 2016
 42-43 C p. 62-65
4 p.
 artikel
324 Recovery using “float” from high intensity stress on growth hormone-like molecules in resistance trained men Kraemer, William J.
42-43 C p.
 artikel
325 Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorder Nemet, Dan
42-43 C p.
 artikel
326 Regulation of fuel metabolism during exercise in hypopituitarism with growth hormone-deficiency (GHD) Zueger, Thomas
 2016
 42-43 C p. 39-44
6 p.
 artikel
327 Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients Morgan, Stuart A.
42-43 C p.
 artikel
328 Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models Yakar, Shoshana
 2016
 42-43 C p. 26-42
17 p.
 artikel
329 Relationship between circulating insulin-like growth factor-1 and blood pressure in adults: A systematic review and meta-analysis of observational studies Leng, Lina
42-43 C p.
 artikel
330 Response to growth hormone therapy in ring chromosome 15: Review and evidence from a new case on possible beneficial effect in neurodevelopment Wannes, Selmen
42-43 C p.
 artikel
331 Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center Vargas-Ortega, Guadalupe
42-43 C p.
 artikel
332 RNA-seq and nuclear proteomics provide insights into the lactation regulation mechanism of goat transfected IGF-I and GH recombinant vectors Fu, Shaodong
42-43 C p.
 artikel
333 RNA transcript expression of IGF-I/PI3K pathway components in regenerating skeletal muscle is sensitive to initial injury intensity Matheny Jr., Ronald W.
 2017
 42-43 C p. 14-21
 artikel
334 Role of ghrelin on growth hormone/insulin-like growth factor-1 axis during endotoxemia Faim, Felipe
42-43 C p. 36-44
 artikel
335 Role of growth hormone signaling pathways in the development of atherosclerosis Ishikawa, Mayumi
42-43 C p.
 artikel
336 Safety and PK/PD correlation of TV-1106, a recombinant fused human albumin-growth hormone, following repeat dose administration to monkeys Ashkenazi, Nurit
 2016
 42-43 C p. 16-21
6 p.
 artikel
337 Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a single-dose, randomized controlled study Klaus, Beate
42-43 C p.
 artikel
338 Screening for genetic causes of growth hormone hypersecretion Rostomyan, Liliya
 2016
 42-43 C p. 52-57
6 p.
 artikel
339 Serum IGF-I concentrations are low in female bodybuilders in the pre-contest phase Monteiro, Diana Paula Pandochi Fernandes
42-43 C p.
 artikel
340 Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients Papadakis, Georgios Z.
 2017
 42-43 C p. 28-34
7 p.
 artikel
341 Serum IGF-I, IGFBP-3 and ALS concentrations and physical performance in young swimmers during a training season Tourinho Filho, H.
 2017
 42-43 C p. 49-54
 artikel
342 Shifting the IGF-axis: An age-related decline in human tear IGF-1 correlates with clinical signs of dry eye Patel, Roshni
 2018
 42-43 C p. 69-73
 artikel
343 Short children born small for gestational age outcomes in the era of growth hormone therapy Zanelli, Santina A.
 2018
 42-43 C p. 8-13
 artikel
344 Short-term evaluation of cardiac morphology, function, metabolism and structure following diagnosis of adult-onset growth hormone deficiency De Cobelli, Francesco
 2019
 42-43 C p. 50-54
 artikel
345 Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis Raisingani, Manish
 2017
 42-43 C p. 13-21
9 p.
 artikel
346 Skeletal muscle-specific overexpression of IGFBP-2 promotes a slower muscle phenotype in healthy but not dystrophic mdx mice and does not affect the dystrophic pathology Swiderski, Kristy
 2016
 42-43 C p. 1-10
10 p.
 artikel
347 Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone? Sze, Lisa
 2019
 42-43 C p. 20-24
 artikel
348 Somatolactogens and diabetic retinopathy Bermea, Kevin Christian
 2018
 42-43 C p. 42-47
 artikel
349 Standardizing protocols dealing with growth hormone receptor gene disruption in mice using the Cre-lox system Duran-Ortiz, Silvana
 2018
 42-43 C p. 52-57
 artikel
350 STAT5B deficiency: Impacts on human growth and immunity Hwa, Vivian
 2016
 42-43 C p. 16-20
5 p.
 artikel
351 “Subclinical atherosclerosis in acromegaly: Possible association with cardiovascular risk factors rather than disease activity” de Almeida, Maria Cristina Costa
42-43 C p.
 artikel
352 Suckling induced insulin-like growth factor-1 (IGF-1) release in mother rats Lékó, András H.
 2017
 42-43 C p. 7-12
6 p.
 artikel
353 Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial. Czepielewski, M.A.
42-43 C p.
 artikel
354 Synergistic effects of tumor necrosis factor-α and insulin-like growth factor-I on survival of human trophoblast-derived BeWo cell line Tanaka, Kei
 2018
 42-43 C p. 34-41
 artikel
355 Testing for growth hormone deficiency in children Richmond, Erick
42-43 C p. 57-60
 artikel
356 The acromegaly registry of ten different centers in Turkey Keskin, Çağlar
42-43 C p.
 artikel
357 The association between change in temporal muscle mass and treatment of acromegaly Sahin, Serdar
42-43 C p.
 artikel
358 The association between treatment and systemic inflammation in acromegaly Wolters, T.L.C.
42-43 C p.
 artikel
359 The clinician's role in promoting resiliency for individuals and families with growth anomalies Silverman, Howard D.
42-43 C p. 34-37
 artikel
360 The coexistence of newly diagnosed acromegaly with primary empty sella: More frequent than expected? Urhan, Emre
42-43 C p.
 artikel
361 The combined frequencies of the IL-6 G-174C and IGFBP3 A-202C polymorphisms among swimmers and runners Ben-Zaken, Sigal
42-43 C p. 17-21
 artikel
362 The combined frequency of IGF and myostatin polymorphism among track & field athletes and swimmers Ben-Zaken, Sigal
 2017
 42-43 C p. 29-32
 artikel
363 The effect of combined functional training on BDNF, IGF-1, and their association with health-related fitness in the multiple sclerosis women Abbaspoor, Elnaz
42-43 C p.
 artikel
364 The effect of growth hormone on bioactive IGF in overweight/obese women Dichtel, Laura E.
 2018
 42-43 C p. 20-27
 artikel
365 The effect of HMB ingestion on the IGF-I and IGF binding protein response to high intensity military training Redd, Michael J.
 2017
 42-43 C p. 55-59
 artikel
366 The effect of methylphenidate on the dopamine and growth hormone response to exercise in children with attention-deficit hyperactivity disorder Nemet, Dan
42-43 C p.
 artikel
367 The effect of milk and rapeseed protein on growth factors in 7–8 year-old healthy children – A randomized controlled trial Grenov, Benedikte
42-43 C p.
 artikel
368 The effect of somatostatin analogues on Ki-67 levels in GH-secreting adenomas Selek, Alev
 2019
 42-43 C p. 1-5
 artikel
369 The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS) Wegmann, Mathilde Gersel
 2017
 42-43 C p. 45-51
7 p.
 artikel
370 The future of growth-promoting therapy Rosenfeld, Ron G.
 2016
 42-43 C p. 43-45
3 p.
 artikel
371 The growth hormone receptor Waters, Michael J.
 2016
 42-43 C p. 6-10
5 p.
 artikel
372 The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas Dogansen, Sema Ciftci
 2016
 42-43 C p. 45-49
5 p.
 artikel
373 The IGF-p53 connection in cancer Conover, Cheryl A.
 2018
 42-43 C p. 25-28
 artikel
374 The IGF system and longitudinal growth in preterm infants in relation to gestational age, birth weight and gender Hellström, Ann
42-43 C p. 46-57
 artikel
375 The impact of adjustments to the diagnostic criteria for biochemical remission in surgically treated patients with acromegaly Kousoula, Konstantina
 2017
 42-43 C p. 16-21
6 p.
 artikel
376 The influence of type 2 diabetes on serum GH and IGF-I levels in hospitalized Japanese patients Suda, Kentaro
 2016
 42-43 C p. 4-10
7 p.
 artikel
377 The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark Kalledsøe, Loa
 2019
 42-43 C p. 33-42
 artikel
378 The insulin-like growth factor-I receptor stimulating activity (IRSA) in health and disease Janssen, Joseph A.M.J.L.
42-43 C p. 16-28
 artikel
379 The inter – Test variability of growth hormone stimulation tests and factors affecting this variability Dori, Eyal Ben
42-43 C p.
 artikel
380 The involvement of Sestrin2 in the effect of IGF-I and leucine on mTROC1 activity in C2C12 and L6 myocytes Sawa, Ran
42-43 C p.
 artikel
381 The necessity of magnetic resonance imaging in the evaluation of pediatric growth hormone deficiency: Lessons from a large academic center Mamilly, Leena
42-43 C p.
 artikel
382 The origin of the p.E180 growth hormone receptor gene mutation Ostrer, Harry
 2016
 42-43 C p. 51-52
2 p.
 artikel
383 The prevalence of IGF-I axis genetic polymorphisms among decathlon athletes Ben-Zaken, Sigal
42-43 C p.
 artikel
384 Therapy with recombinant human IGF-1 for children with primary insulin-like growth factor-I deficiency Backeljauw, Philippe
42-43 C p. 22-26
 artikel
385 The regulation of proliferation and apoptosis in hepatocellular carcinoma via insulin-like growth factor 1 receptor Xu, Guanjun
42-43 C p.
 artikel
386 Thermodynamic analysis of r-hGH-polymer surface Interaction using isothermal titration calorimetry Parikh, Vaishnavi
 2018
 42-43 C p. 86-93
 artikel
387 The role of growth hormone for fertility in women with hypopituitarism Chen, Julie
42-43 C p.
 artikel
388 The role of growth hormone receptor in β cell function Wang, Shuang
 2017
 42-43 C p. 30-35
6 p.
 artikel
389 The significance of estrogen receptors in acromegaly: Are they useful as predictors of prognosis and therapy regimen? Ozturk, Selma
42-43 C p.
 artikel
390 The single IGF-1 partial deficiency is responsible for mitochondrial dysfunction and is restored by IGF-1 replacement therapy Olleros Santos-Ruiz, M.
 2017
 42-43 C p. 21-32
12 p.
 artikel
391 The somatotropic axis and aging: Benefits of endocrine defects Bartke, Andrzej
 2016
 42-43 C p. 41-45
5 p.
 artikel
392 The timing of administration of exogenous glucocorticoid affects 24hour growth hormone secretion in children Wolthers, Ole D.
 2017
 42-43 C p. 40-44
5 p.
 artikel
393 The true story of the “strong and gentle” Acciano's Giant Sirufo, Maria Maddalena
42-43 C p.
 artikel
394 Time course and reaction types of serum IGF-1 and its relationship to BMI and leptin regarding inpatients with anorexia nervosa Hellwig-Walter, Christiane
42-43 C p.
 artikel
395 Tissue-specific disruption of the growth hormone receptor (GHR) in mice: An update Duran-Ortiz, Silvana
42-43 C p. 1-5
 artikel
396 Traditional and novel aspects of the metabolic actions of growth hormone Sperling, Mark A.
 2016
 42-43 C p. 69-75
7 p.
 artikel
397 Treatment of growth failure in the absence of GH signaling: The Ecuadorian experience Guevara-Aguirre, Jaime
 2018
 42-43 C p. 53-56
 artikel
398 Treatment of the adult growth hormone deficiency syndrome with growth hormone: What are the implications for other hormone replacement therapies for hypopituitarism? Fierro, Gustavo
42-43 C p.
 artikel
399 Two types of rat pituitary somatotrophs secrete growth hormone with different biological and immunological profiles Grindeland, Richard E.
 2017
 42-43 C p. 52-56
5 p.
 artikel
400 Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR) Rothenbuhler, Anya
 2017
 42-43 C p. 11-15
5 p.
 artikel
401 Two years in growth hormone 2017–18 Clayton, P.E.
42-43 C p. 60-64
 artikel
402 Two years in IGF research Forbes, Briony E
 2016
 42-43 C p. 70-74
5 p.
 artikel
403 Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment Palmieri, Viviana Valeria
42-43 C p. 9-15
 artikel
404 Unique near-complete deletion of GLI2 in a patient with combined pituitary hormone deficiency and post-axial polydactyly Elizabeth, Melitza S.M.
42-43 C p. 35-41
 artikel
405 Using site-directed mutagenesis to further the understanding of insulin receptor-insulin like growth factor-1 receptor heterodimer structure Turvey, Samuel
42-43 C p.
 artikel
406 Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency Ciresi, Alessandro
 2016
 42-43 C p. 71-77
7 p.
 artikel
407 Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly Rotermund, Roman
 2018
 42-43 C p. 64-70
 artikel
408 Variability in adherence to rhGH treatment: Socioeconomic causes and effect on children's growth De Pedro, Silvina
 2016
 42-43 C p. 32-35
4 p.
 artikel
409 Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess Ciresi, A.
 2017
 42-43 C p. 35-42
8 p.
 artikel
410 Vitamin D increases IGF-I and insulin levels in experimental diabetic rats Derakhshanian, H.
 2017
 42-43 C p. 57-59
3 p.
 artikel
411 Vitamin D supplementation affects the IGF system in men after acute exercise Darr, Rachel L.
 2016
 42-43 C p. 45-51
7 p.
 artikel
412 Volumetric Absorptive Microsampling (VAMS) technology for IGF-1 quantification by automated chemiluminescent immunoassay in dried blood Marchand, A.
42-43 C p. 27-34
 artikel
                             412 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland